Cancer Diseases
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) (NCT00886353) | Apeiron Biologics | 2009-04-01 |
Track Cancer Diseases automatically
Every clearance here is in the API, with alerts when new ones post.